XARMODY Trademark

Trademark Overview


On Friday, November 18, 2011, a trademark application was filed for XARMODY with the United States Patent and Trademark Office. The USPTO has given the XARMODY trademark a serial number of 85476678. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2016. This trademark is owned by Eli Lilly and Company. The XARMODY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; ...
xarmody

General Information


Serial Number85476678
Word MarkXARMODY
Filing DateFriday, November 18, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 20, 2012

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, February 16, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 15, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 29, 2015EXTENSION 5 GRANTED
Wednesday, June 24, 2015EXTENSION 5 FILED
Wednesday, June 24, 2015TEAS EXTENSION RECEIVED
Friday, December 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 11, 2014EXTENSION 4 GRANTED
Monday, December 8, 2014EXTENSION 4 FILED
Monday, December 8, 2014TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014EXTENSION 3 GRANTED
Tuesday, June 10, 2014EXTENSION 3 FILED
Tuesday, June 10, 2014TEAS EXTENSION RECEIVED
Friday, December 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2013EXTENSION 2 GRANTED
Tuesday, December 17, 2013EXTENSION 2 FILED
Tuesday, December 17, 2013TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013EXTENSION 1 GRANTED
Wednesday, July 10, 2013EXTENSION 1 FILED
Saturday, August 3, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 10, 2013TEAS EXTENSION RECEIVED
Tuesday, January 15, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 20, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 20, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 31, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 15, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 15, 2012ASSIGNED TO LIE
Monday, October 1, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 31, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 15, 2012NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, March 15, 2012PRIORITY ACTION E-MAILED
Thursday, March 15, 2012PRIORITY ACTION WRITTEN
Tuesday, March 6, 2012ASSIGNED TO EXAMINER
Monday, November 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 22, 2011NEW APPLICATION ENTERED IN TRAM